In line with these results, we observed that Analog-1 reduced the intracellular glutamine and glutamate concentrations in both NB and melanoma cells likely through the induction of SLC1A5 and SLC38A2 ubiquitination and subsequent degradation. Here, SLC1A5 is linked to melanoma.